Sort by
Refine Your Search
-
Listed
-
Employer
- University of Oxford
- ;
- KINGS COLLEGE LONDON
- University of London
- Durham University
- Heriot Watt University
- UNIVERSITY OF VIENNA
- DURHAM UNIVERSITY
- King's College London
- University of Birmingham
- University of Newcastle
- Aston University
- Heriot-Watt University;
- Medical Research Council
- Northumbria University;
- University of Dundee;
- University of Liverpool
- University of Oxford;
- 8 more »
- « less
-
Field
-
applicants for a 6-month paternity leave replacement who have a strong interest in using computational methods such as cognitive and psychophysiological modeling, (Bayesian) statistics and optimal experimental
-
into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. You will hold a relevant PhD/DPhil, together with sufficient specialist knowledge in normal and malignant
-
targets. You will hold a relevant PhD/DPhil, together with sufficient specialist knowledge in normal and malignant hematopoiesis research. Experience generating genomics data from leukaemia samples with
-
help develop and characterise advanced patient-derived tumour models and use them to test promising therapeutic targets that exploit vulnerabilities caused by loss of the SMARCB1 gene. This role offers
-
dedicated high-performance computing implementations. Technology transfer to magnetic resonance imaging in medicine is a secondary target. Key Duties and Responsibilities The postholder will develop new image
-
) Experience of working with multiple stakeholders in complex systems. Experience in large scale simulations Experience in Bayesian methods Experience using CRAFTY agent based model Full details of the role and
-
precancers and developing targeted interventions, including vaccines, to intercept them. The project focuses on designing, validating, and preclinically testing neoepitope-based mRNA vaccines to prevent BRCA
-
precancers and developing targeted interventions, including vaccines, to intercept them. The project focuses on designing, validating, and preclinically testing neoepitope-based mRNA vaccines to prevent BRCA
-
collections of patient samples from different clinical studies, which we analyse by both genome-wide and targeted methods for sensitive mutation detection. We aim to develop novel tools for cancer diagnostics
-
culture and organoids to ensure data is clinically relevant. Our overarching aim is to utilise these techniques to identify therapeutic targets to which we can generate effective treatments. The post would